159 related articles for article (PubMed ID: 17373274)
1. [Genetic iron overload diseases: a deeply changing world].
Brissot P; Troadec MB; Le Lan C; Lorho R; Gaboriau F; Lescoat G; Jouanolle AM; Loréal O
Nephrol Ther; 2006 Nov; 2 Suppl 5():S298-303. PubMed ID: 17373274
[TBL] [Abstract][Full Text] [Related]
2. Current approach to hemochromatosis.
Brissot P; Troadec MB; Bardou-Jacquet E; Le Lan C; Jouanolle AM; Deugnier Y; Loréal O
Blood Rev; 2008 Jul; 22(4):195-210. PubMed ID: 18430498
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of hepcidin in obese patients: impact on phenotypic expression of hemochromatosis and pathophysiology of dysmetabolic iron overload syndrome.
Lainé F; Deugnier Y
Gastroenterology; 2006 Dec; 131(6):2028. PubMed ID: 17188970
[No Abstract] [Full Text] [Related]
4. [Hereditary iron overload].
Brissot P; Bardou-Jacquet E; Latournerie M; Ropert-Bouchet M; Island ML; Loréal O; Jouanolle AM
Pathol Biol (Paris); 2010 Oct; 58(5):316-23. PubMed ID: 19942367
[TBL] [Abstract][Full Text] [Related]
5. [Genetics of hereditary iron overload].
Le Gall JY; Jouanolle AM; Fergelot P; Mosser J; David V
Bull Acad Natl Med; 2004; 188(2):247-62; discussion 262-3. PubMed ID: 15506716
[TBL] [Abstract][Full Text] [Related]
6. Review article: the iron overload syndromes.
Siddique A; Kowdley KV
Aliment Pharmacol Ther; 2012 Apr; 35(8):876-93. PubMed ID: 22385471
[TBL] [Abstract][Full Text] [Related]
7. [Genetic iron overloads and hepatic insulin-resistance iron overload syndrome: an update].
Ruivard M
Rev Med Interne; 2009 Jan; 30(1):35-42. PubMed ID: 18584923
[TBL] [Abstract][Full Text] [Related]
8. [Defective iron metabolism in genetic hemochromatosis. The mechanisms remain unknown in spite of genetic advances].
Stål P; Hagen K; Hultcrantz R
Lakartidningen; 1998 Aug; 95(32-33):3430-5. PubMed ID: 9725962
[TBL] [Abstract][Full Text] [Related]
9. Iron overload.
Siah CW; Trinder D; Olynyk JK
Clin Chim Acta; 2005 Aug; 358(1-2):24-36. PubMed ID: 15885682
[TBL] [Abstract][Full Text] [Related]
10. The molecular genetics of haemochromatosis.
Le Gac G; Férec C
Eur J Hum Genet; 2005 Nov; 13(11):1172-85. PubMed ID: 16132052
[TBL] [Abstract][Full Text] [Related]
11. Molecular diagnosis of genetic iron-overload disorders.
Brissot P; Bardou-Jacquet E; Troadec MB; Mosser A; Island ML; Detivaud L; Loréal O; Jouanolle AM
Expert Rev Mol Diagn; 2010 Sep; 10(6):755-63. PubMed ID: 20843199
[TBL] [Abstract][Full Text] [Related]
12. Iron and the liver: update 2008.
Deugnier Y; Brissot P; Loréal O
J Hepatol; 2008; 48 Suppl 1():S113-23. PubMed ID: 18304682
[TBL] [Abstract][Full Text] [Related]
13. The dysmetabolic iron overload syndrome is clinically and genetically distinct from HFE-related genetic hemochromatosis.
Rovati A; Bergamaschi G; Casula S; Cerani P; Grasso M; Cazzola M
Haematologica; 1999 Feb; 84(2):182-3. PubMed ID: 10091420
[No Abstract] [Full Text] [Related]
14. [Hemochromatosis--from an underdiagnosed curiosity to a common disease].
Hagve TA; Asberg A; Ulvik R; Borch-Iohnsen B; Thorstensen K
Tidsskr Nor Laegeforen; 2009 Apr; 129(9):863-6. PubMed ID: 19415085
[TBL] [Abstract][Full Text] [Related]
15. [Iron metabolism and its exploration in clinical biology].
Brissot P; Pigeon C; Moirand R; Guyader D; Mendler MH; Sapey T; Deugnier Y; Lescoat G; Loréal O
Ann Biol Clin (Paris); 1998 Jul; 56 Spec No():5-10. PubMed ID: 9827209
[No Abstract] [Full Text] [Related]
16. Current approaches to the management of hemochromatosis.
Brissot P; de Bels F
Hematology Am Soc Hematol Educ Program; 2006; ():36-41. PubMed ID: 17124037
[TBL] [Abstract][Full Text] [Related]
17. Chronic iron overload and toxicity: clinical chemistry perspective.
Kang JO
Clin Lab Sci; 2001; 14(3):209-19; quiz 222. PubMed ID: 11517632
[TBL] [Abstract][Full Text] [Related]
18. Mutation analysis of hepcidin and ferroportin genes in Italian prospective blood donors with iron overload.
Duca L; Delbini P; Nava I; Vaja V; Fiorelli G; Cappellini MD
Am J Hematol; 2009 Sep; 84(9):592-3. PubMed ID: 19610021
[TBL] [Abstract][Full Text] [Related]
19. Aceruloplasminemia in an asymptomatic patient with a new mutation. Diagnosis and family genetic analysis.
Pérez-Aguilar F; Burguera JA; Benlloch S; Berenguer M; Rayón JM
J Hepatol; 2005 Jun; 42(6):947-9. PubMed ID: 15885371
[TBL] [Abstract][Full Text] [Related]
20. Identification and in silico characterization of a novel compound heterozygosity associated with hereditary aceruloplasminemia.
Hofmann WP; Welsch C; Takahashi Y; Miyajima H; Mihm U; Krick C; Zeuzem S; Sarrazin C
Scand J Gastroenterol; 2007 Sep; 42(9):1088-94. PubMed ID: 17710675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
